Improving Pregnancy Care Through Advanced Diagnostic Testing

Introduction

Early identification of pregnancy complications helps healthcare professionals make timely decisions and provide appropriate care. Tests that assess the risk of preterm birth and detect premature rupture of membranes are important tools in managing high-risk pregnancies.

The Preterm Birth and PROM Testing Market is gaining attention as healthcare providers focus on maternal health, early diagnosis, and improved prenatal care. According to Straits Research, the global market was valued at USD 2.62 billion in 2025 and is projected to reach USD 10.22 billion by 2034, growing at a CAGR of 16.33% from 2026 to 2034.

What Are Preterm Birth and PROM Tests?

Preterm birth refers to a baby being born before 37 completed weeks of pregnancy. Premature rupture of membranes (PROM) occurs when the amniotic sac breaks before labor begins. When this happens before 37 weeks, it is called preterm prelabor rupture of membranes (PPROM).

According to the World Health Organization, approximately 13.4 million babies were born preterm worldwide in 2020. These complications highlight the importance of appropriate prenatal assessment and timely medical care.

Key Testing Methods Driving Market Demand

Ultrasound Testing

Ultrasound helps healthcare professionals assess cervical changes, amniotic fluid levels, and fetal development. It is a widely used tool in pregnancy monitoring and can support decisions about further examination when preterm labor is suspected.

Biochemical Marker Tests

Tests that detect biomarkers such as placental alpha-microglobulin-1 (PAMG-1) and insulin-like growth factor binding protein-1 (IGFBP-1) can help assess suspected membrane rupture. These tests are particularly useful when a physical examination does not provide a clear answer.

Fetal Fibronectin Testing

Fetal fibronectin (fFN) testing can help assess the likelihood of preterm birth in certain clinical situations. Doctors interpret the results alongside pregnancy history, gestational age, symptoms, and other examination findings.

Pelvic Examination and Traditional Tests

Speculum examination, pooling assessment, nitrazine testing, and ferning tests are among the methods used to evaluate suspected membrane rupture. The appropriate approach depends on clinical guidelines and the patient's condition.

Major Factors Supporting Market Growth

Rising Demand for Prenatal Care

Greater attention to maternal and fetal health is encouraging healthcare providers to improve access to pregnancy screening and diagnostic services. Early assessment can help identify complications and guide decisions about monitoring and treatment.

Growth of Point-of-Care Testing

Rapid diagnostic tests can provide results closer to the point of care, supporting timely clinical decisions. Manufacturers are working to improve test reliability, ease of use, and accessibility, particularly in settings with limited diagnostic resources.

Advances in Diagnostic Technology

Improvements in biomarker detection, testing materials, and diagnostic procedures are expanding the options available to healthcare professionals. More accessible testing solutions may help healthcare facilities manage suspected pregnancy complications more efficiently.

Challenges Facing the Market

Despite growing demand, testing providers face challenges related to product costs, diagnostic accuracy, availability, and regulatory requirements. False-positive and false-negative results can affect clinical decisions, making appropriate test selection and interpretation essential.

Access also varies across regions. Some healthcare facilities have limited equipment, trained personnel, or funding for advanced diagnostic tests. Affordable products and reliable supply networks will therefore remain important for market expansion.

Regional Growth Opportunities

North America represents a major market, supported by established healthcare infrastructure and access to maternal diagnostic technologies. Europe also benefits from developed prenatal care services and the adoption of newer testing methods.

Asia-Pacific offers opportunities as healthcare infrastructure expands and awareness of pregnancy complications increases. However, access to reliable testing varies by country according to affordability, healthcare investment, and the availability of trained professionals.

Future Outlook

The future of this market will depend on improvements in rapid testing, biomarker-based diagnostics, and access to prenatal care. Manufacturers that prioritize reliable results, practical costs, and ease of use may be better positioned to serve healthcare providers.

Clinical assessment will remain essential because no single diagnostic test is suitable for every pregnancy complication. As testing technologies advance, combining appropriate diagnostic methods with professional medical judgment will continue to support better pregnancy care.

Frequently Asked Questions

What drives the market?

Key drivers include increasing demand for prenatal care, improvements in diagnostic technologies, and greater use of rapid testing methods.

Which tests are commonly used?

Common methods include ultrasound, fetal fibronectin testing, biochemical marker tests, and clinical examination for suspected membrane rupture.

Why is early testing important?

Appropriate testing helps healthcare professionals assess suspected complications and make timely decisions about monitoring and treatment.

Read More: https://straitsresearch.com/report/preterm-birth-and-prom-testing-market

Conclusion

Growing attention to maternal health and advances in prenatal diagnostics are creating opportunities in this industry. Continued improvements in test reliability, affordability, and accessibility will be important for supporting healthcare providers and managing high-risk pregnancies.

Explore the full market report from Straits Research for detailed market estimates, testing segments, regional analysis, and forecasts.